Bids Are Invited For Central Purchase - Medicines Court Service Vii

Acebrophylline - Active Ingredient: Acebrophylline; Concentration/Dosage: 10 Mg/Ml; Pharmaceutical Form: Syrup; Presentation: 120 Ml Bottle; Component: Cop, Methylprednisolone Aceponate - Active Ingredient: Methylprednisolone Aceponate; Concentration/Dosage: 1 Mg/G; Pharmaceutical Form: Dermatologic Cream, Hyaluronic Acid + Associations - Active Ingredient (1): Hyaluronic Acid; Active Ingredient (2): Sorbitol; Concentration/Dosage: 80 Mg + 160 Mg; Form F, Pamidronic Acid - Active Ingredient: Pamidronic Acid; Concentration/Dosage: 60 Mg; Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Aprese, Adalimumab - Active Ingredient: Adalimumab; Concentration/Dosage: 20 Mg/0.2 Ml; Pharmaceutical Form: Injectable Solution; Presentation: Filled Syringe, Follitropin Alfa - Active Ingredient: Follitropin Alfa; Concentration/Dosage: 300 Iu (22 Mcg); Pharmaceutical Form: Injectable Solution; Presentation: Pen, Anifrolumab - Active Ingredient: Anifrolumab; Concentration/Dosage: 300 Mg/2 Ml (150 Mg/Ml); Pharmaceutical Form: Solution For Dilution For Infusion; A, Amlodipine + Associations - Active Ingredient (1): Amlodipine, Besylate; Active Ingredient (2): Perindopril Arginine; Concentration/Dosage: 5 Mg + 7 Mg; Fo, Bamifylline - Active Ingredient: Bamifylline, Hydrochloride; Concentration/Dosage: 300 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Compone, Hydrochloride; Concentration/Dosage: 600 Mg; Pharmaceutical Form: Coated Tablet; Presentation: .; Compone, Beclomethasone - Active Ingredient: Beclomethasone, Dipropionate; Concentration/Dosage: 400 Mcg/Ml; Pharmaceutical Form: Nebulization Suspension; Aprese, Beclomethasone + Associations - Active Ingredient (1): Beclomethasone, Dipropionate; Active Ingredient (2): Formoterol, Fumarate; Concentration/Dosage: 200 M, Dipropionate; Active Ingredient (2): Salbutamol, Sulfate; Concentration/Dosage: 400 Mc, Betamethasone - Active Ingredient: Betamethasone, Valerate; Concentration/Dosage: 1 Mg/G; Pharmaceutical Form: Hair Solution; Presentation: 50 Ml Bottle, Bilastine - Active Ingredient: Bilastine; Concentration/Dosage: 20 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Buclizine - Active Ingredient: Buclizine, Dihydrochloride; Concentration/Dosage: 25 Mg; Pharmaceutical Form: Tablet; Presentation: .; Component: .;, Budesonide - Active Ingredient: Budesonide; Concentration/Dosage: 9 Mg; Pharmaceutical Form: Modified Release Coated Tablet; Presentation: Budesonide + Associations - Active Ingredient: Budesonide + Formoterol, Fumarate Dihydrate; Concentration/Dosage: 100 Mcg + 6 Mcg; Pharmaceutical Form: C, Canakinumab - Active Ingredient: Canakinumab; Concentration/Dosage: 150 Mg; Pharmaceutical Form: Injectable Solution; Presentation: Vial-Ampule; Comp, Carisoprodol + Associations - Active Ingredient (1): Carisoprodol; Active Ingredient (2): Dipyrone + Cyanocobalamin + Thiamine + Pyridoxine; Concentration/D, Carmelose Sodica + Associations - Active Ingredient (1): Carmelose Sodica; Active Ingredient (2): Glycerin; Concentration/Dosage: 5 Mg/Ml + 9 Mg/Ml; Form, Certolizumab Pegol - Active Ingredient: Certolizumab Pegol; Concentration/Dosage: 200 Mg/Ml; Pharmaceutical Form: Injectable Solution; Presentation: Seri, Ketotifen - Active Ingredient: Ketotifen; Concentration/Dosage: 0.2 Mg/Ml; Pharmaceutical Form: Syrup; Presentation: 120 Ml Bottle; Component: M-Cup, Cyclobenzaprine - Active Ingredient: Cyclobenzaprine, Hydrochloride; Concentration/Dosage: 15 Mg; Pharmaceutical Form: Libe Hard Capsule